Phibro Animal Health ROE 2012-2019 | PAHC

Current and historical return on equity (ROE) values for Phibro Animal Health (PAHC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Phibro Animal Health ROE for the three months ending June 30, 2019 was 29.99%.
Phibro Animal Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.06B $0.22B 26.60%
2019-03-31 $0.07B $0.21B 34.17%
2018-12-31 $0.07B $0.21B 38.02%
2018-09-30 $0.07B $0.19B 35.57%
2018-06-30 $0.07B $0.19B 36.72%
2018-03-31 $0.06B $0.19B 34.42%
2017-12-31 $0.06B $0.17B 39.55%
2017-09-30 $0.07B $0.17B 47.55%
2017-06-30 $0.06B $0.15B 50.69%
2017-03-31 $0.06B $0.14B 57.66%
2016-12-31 $0.06B $0.11B 61.62%
2016-09-30 $0.08B $0.10B 94.12%
2016-06-30 $0.08B $0.09B 136.07%
2016-03-31 $0.08B $0.08B 169.57%
2015-12-31 $0.08B $0.05B 235.66%
2015-09-30 $0.06B $0.02B 235.29%
2015-06-30 $0.06B $0.03B 237.62%
2015-03-31 $0.03B $0.02B 148.84%
2014-12-31 $0.02B $0.03B -525.00%
2014-09-30 $0.01B $0.02B -85.71%
2014-06-30 $-0.00B $0.02B 25.00%
2013-12-31 $0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.885B $0.828B
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. The Company offers vaccines, anti-infectives, disinfectants, mineral premixes, medicated feed additives, antimicrobials, performance chemicals, and cosmetics. Phibro Animal Health Corporation is based in Teaneck, New Jersey.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.155B 20.38
Abbott Laboratories (ABT) United States $144.891B 27.24
Stryker (SYK) United States $80.414B 27.81
Boston Scientific (BSX) United States $53.574B 25.99
Baxter (BAX) United States $44.796B 27.16
EssilorLuxottica Societe Anonyme (ESLOY) France $32.784B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.311B 18.12
Coloplast (CLPBY) Denmark $25.596B 40.86
Lonza Group Ag (LZAGY) Switzerland $25.166B 0.00
Terumo (TRUMY) Japan $23.897B 29.82
Smith & Nephew SNATS (SNN) United Kingdom $20.556B 0.00
ResMed (RMD) United States $18.755B 35.74
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.968B 53.44
Insulet (PODD) United States $9.367B 555.07
Perrigo (PRGO) Ireland $7.321B 13.49
Canopy Growth (CGC) Canada $6.992B 0.00
Hill-Rom Holdings (HRC) United States $6.758B 20.15
Haemonetics (HAE) United States $6.423B 48.47
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.868B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.717B 0.00
Neogen (NEOG) United States $3.401B 56.90
NuVasive (NUVA) United States $3.312B 26.40
ICU Medical (ICUI) United States $3.149B 20.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.522B 0.00
Quidel (QDEL) United States $2.431B 24.14
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
National Vision Holdings (EYE) United States $1.919B 41.42
Cardiovascular Systems (CSII) United States $1.617B 0.00
Aphria (APHA) $1.368B 0.00
VAREX IMAGING (VREX) United States $1.117B 25.74
AtriCure (ATRC) United States $1.022B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.847B 21.60
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.778B 18.37
Omeros (OMER) United States $0.764B 0.00
Lantheus Holdings (LNTH) United States $0.742B 19.50
LeMaitre Vascular (LMAT) United States $0.670B 39.72
Cerus (CERS) United States $0.633B 0.00
Surmodics (SRDX) United States $0.607B 115.31
MacroGenics (MGNX) United States $0.562B 0.00
Quanterix (QTRX) United States $0.554B 0.00
OraSure Technologies (OSUR) United States $0.510B 23.60
TG Therapeutics (TGTX) United States $0.507B 0.00
Meridian Bioscience (VIVO) United States $0.423B 13.21
Owens & Minor (OMI) United States $0.406B 12.17
Zynex (ZYXI) United States $0.384B 40.79
Utah Medical Products (UTMD) United States $0.342B 25.05
BioLife Solutions (BLFS) United States $0.329B 101.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.321B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.223B 0.00
Vapotherm (VAPO) United States $0.179B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.148B 0.00
Female Health (VERU) United States $0.137B 0.00
Fonar (FONR) United States $0.131B 9.16
InfuSystems Holdings (INFU) United States $0.129B 0.00
Liberty Health Sciences (LHSIF) $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
Chimerix (CMRX) United States $0.088B 0.00
United-Guardian (UG) United States $0.086B 20.46
Nephros (NEPH) United States $0.077B 0.00
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.059B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00